Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human T-lymphotropic Virus I & II”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Ended earlyNCT04362007
What this trial is testing

A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
Otsuka Pharmaceutical Co., Ltd. 8
Testing effectiveness (Phase 2)Study completedNCT00001941
What this trial is testing

Anti-Tac for Treatment of Leukemia

Who this might be right for
HTLV-I InfectionT Cell Leukemia
National Cancer Institute (NCI) 34
Not applicableUnknownNCT01467024
What this trial is testing

Evaluation of the MP Diagnostics HTLV Blot 2.4

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 600
Testing effectiveness (Phase 2)Study completedNCT01274533
What this trial is testing

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

Who this might be right for
Adult T Cell Leukemia/Lymphoma
Columbia University 4
Not applicableStudy completedNCT01149837
What this trial is testing

Evaluation of InnoLIA HTLV I/II Score

Who this might be right for
Human T-Lymphotrophic Virus Type I and/or Type II
Creative Testing Solutions 3,305
Testing effectiveness (Phase 2)Ended earlyNCT00117845
What this trial is testing

Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia

Who this might be right for
Leukemia, Adult T-Cell
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Looking for participantsNCT07075328
What this trial is testing

A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma

Who this might be right for
Adult T-Cell Leukemia/Lymphoma (ATLL)
Otsuka Medical Devices Co., Ltd. Japan 49
Testing effectiveness (Phase 2)Study completedNCT02631746
What this trial is testing

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Who this might be right for
Acute Adult T-Cell Leukemia/LymphomaAdult T-Cell Leukemia/LymphomaChronic Adult T-Cell Leukemia/Lymphoma+3 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Ended earlyNCT01712659
What this trial is testing

Ruxolitinib for Adult T-Cell Leukemia

Who this might be right for
T Cell Leukemia, AdultLeukemia, Adult T-CellT Cell Leukemia, HTLV I Associated
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT01000285
What this trial is testing

EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma

Who this might be right for
Leukemia-Lymphoma, Adult T-Cell
Washington University School of Medicine 18
Not applicableStudy completedNCT00097006
What this trial is testing

Retrovirus Epidemiology Donor Study-II (REDS-II)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+10 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Looking for participantsNCT04799288
What this trial is testing

Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis

Who this might be right for
HAM/TSP
National Institute of Neurological Disorders and Stroke (NINDS) 24
Post-approval studies (Phase 4)Ended earlyNCT00854581
What this trial is testing

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

Who this might be right for
LymphomaPrecancerous/Nonmalignant Condition
University of Miami 13
Testing effectiveness (Phase 2)Study completedNCT00061048
What this trial is testing

Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Acute T-Cell Leukemia-Lymphoma
National Cancer Institute (NCI) 29
Not applicableStudy completedNCT00005278
What this trial is testing

Retrovirus Epidemiology Donor Study I (REDS I)

Who this might be right for
Acquired Immunodeficiency SyndromeBlood DonorsBlood Transfusion+6 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT00041327
What this trial is testing

Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium 19
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Testing effectiveness (Phase 2)WithdrawnNCT01620736
What this trial is testing

Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load

Who this might be right for
Human T-cell Leukemia Virus Type 1 Infection
Washington University School of Medicine
Post-approval studies (Phase 4)Study completedNCT03226119
What this trial is testing

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 150
Not applicableStudy completedNCT01050881
What this trial is testing

Notification of Donors With Positive Microbiology Markers

Who this might be right for
Human Immunodeficiency VirusHepatitis BHepatitis C+2 more
NHS Blood and Transplant 217